jamesitaliaFeb 8, 20233 minBrickBio Achieves Stable Cell Line in Record Timeframe: 5x Faster with 7x Enhanced ProductionBOSTON, February 7, 2023 /PRNewswire/ -- BrickBio Highlights Unique Advantages from the Proprietary "VADER" System, published on Dec 22,...
jamesitaliaApr 25, 20223 minBrickBio Unveils Powerful Engineered RNA Therapeutic Modification Platform at AACR 2022BOSTON, April 25, 2022 /PRNewswire/ -- BrickBio Highlights Powerful Advantage of the Company's BrickADCs™, Protein Origami™, and...
jamesitaliaNov 2, 20212 minBrickBio Announces Rapid V2, eCLIC™, Chemistry and Cytokine External Partner CollaborationBOSTON, Nov. 2, 2021 /PRNewswire/ -- BrickBio, the leader in site-specific bioconjugation, announced a rapid next-generation conjugation...
jamesitaliaOct 27, 20213 minWorld's First Antibody Drug Conjugate (ADC) Rapid Predictive SiteSelect™ Panel LaunchedBOSTON, Oct. 26, 2021 /PRNewswire/ -- A Rapid Predictive Site-Selection Panel for ADC-Linker-Payload Optimization BrickBio, the leader in...